These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32613146)

  • 1. Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension.
    Prinsen JK; Kannankeril PJ; Sidorova TN; Yermalitskaya LV; Boutaud O; Zagol-Ikapitte I; Barnett JV; Murphy MB; Subati T; Stark JM; Christopher IL; Jafarian-Kerman SR; Saleh MA; Norlander AE; Loperena R; Atkinson JB; Fogo AB; Luther JM; Amarnath V; Davies SS; Kirabo A; Madhur MS; Harrison DG; Murray KT
    JACC Basic Transl Sci; 2020 Jun; 5(6):602-615. PubMed ID: 32613146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
    Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device.
    O'Neill MJ; Yoneda ZT; Crawford DM; Ye F; Ao M; Pitchford LM; Rathmacher JA; Murray KT; Akers WS; Roden DM; Michaud GF; Shoemaker MB
    Trials; 2021 Aug; 22(1):576. PubMed ID: 34454591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells.
    Sidorova TN; Yermalitskaya LV; Mace LC; Wells KS; Boutaud O; Prinsen JK; Davies SS; Roberts LJ; Dikalov SI; Glabe CG; Amarnath V; Barnett JV; Murray KT
    J Mol Cell Cardiol; 2015 Feb; 79():295-302. PubMed ID: 25463275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic Peptide Oligomers Cause Proarrhythmic Metabolic and Electrophysiological Effects in Atrial Myocytes.
    Yang Z; Subati T; Kim K; Murphy MB; Dougherty OP; Christopher IL; Van Amburg JC; Woodall KK; Barnett JV; Murray KT
    Circ Arrhythm Electrophysiol; 2022 Mar; 15(3):e010636. PubMed ID: 35212578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
    Murphy MB; Yang Z; Subati T; Farber-Eger E; Kim K; Blackwell DJ; Fleming MR; Stark JM; Van Amburg JC; Woodall KK; Van Beusecum JP; Agrawal V; Smart CD; Pitzer A; Atkinson JB; Fogo AB; Bastarache JA; Kirabo A; Wells QS; Madhur MS; Barnett JV; Murray KT
    Cardiovasc Res; 2024 Jul; 120(8):899-913. PubMed ID: 38377486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
    Shang L; Weng X; Wang D; Yue W; Mernaugh R; Amarnath V; Weir EK; Dudley SC; Xu Y; Hou M; Chen Y
    Free Radic Biol Med; 2019 Sep; 141():291-298. PubMed ID: 31254620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolevuglandins Scavenger Ameliorates Myocardial Ischemic Injury by Suppressing Oxidative Stress, Apoptosis, and Inflammation.
    Guo J; Xu F; Ji H; Jing Y; Shen L; Weng X; Hu L
    Front Cell Dev Biol; 2022; 10():836035. PubMed ID: 35356291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans.
    Rathmacher JA; Fuller JC; Abumrad NN; Flynn CR
    Inflammation; 2023 Aug; 46(4):1343-1352. PubMed ID: 36935449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr
    Tao H; Huang J; Yancey PG; Yermalitsky V; Blakemore JL; Zhang Y; Ding L; Zagol-Ikapitte I; Ye F; Amarnath V; Boutaud O; Oates JA; Roberts LJ; Davies SS; Linton MF
    Nat Commun; 2020 Aug; 11(1):4084. PubMed ID: 32796843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IsoLGs (Isolevuglandins) Drive Neutrophil Migration in Hypertension and Are Essential for the Formation of Neutrophil Extracellular Traps.
    Krishnan J; de la Visitación N; Hennen EM; Amarnath V; Harrison DG; Patrick DM
    Hypertension; 2022 Aug; 79(8):1644-1655. PubMed ID: 35686559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
    Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
    Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.
    Dikalova A; Mayorov V; Xiao L; Panov A; Amarnath V; Zagol-Ikapitte I; Vergeade A; Ao M; Yermalitsky V; Nazarewicz RR; Boutaud O; Lopez MG; Billings FT; Davies S; Roberts LJ; Harrison DG; Dikalov S
    Hypertension; 2020 Dec; 76(6):1980-1991. PubMed ID: 33012204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
    Schmalstieg-Bahr K; Gladstone DJ; Hummers E; Suerbaum J; Healey JS; Zapf A; Köster D; Werhahn SM; Wachter R
    Eur J Gen Pract; 2024 Dec; 30(1):2327367. PubMed ID: 38497412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophilic reactive aldehydes as a therapeutic target in colorectal cancer prevention and treatment.
    Gobert AP; Asim M; Smith TM; Williams KJ; Barry DP; Allaman MM; McNamara KM; Hawkins CV; Delgado AG; Zhao S; Piazuelo MB; Washington MK; Coburn LA; Rathmacher JA; Wilson KT
    Oncogene; 2023 May; 42(20):1685-1691. PubMed ID: 37037901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology?
    Sidorova TN; Mace LC; Wells KS; Yermalitskaya LV; Su PF; Shyr Y; Atkinson JB; Fogo AB; Prinsen JK; Byrne JG; Petracek MR; Greelish JP; Hoff SJ; Ball SK; Glabe CG; Brown NJ; Barnett JV; Murray KT
    J Am Heart Assoc; 2014 Dec; 3(6):e001384. PubMed ID: 25468655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
    Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
    Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.
    Kerr B; Brandon L
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus.
    Patrick DM; de la Visitación N; Krishnan J; Chen W; Ormseth MJ; Stein CM; Davies SS; Amarnath V; Crofford LJ; Williams JM; Zhao S; Smart CD; Dikalov S; Dikalova A; Xiao L; Van Beusecum JP; Ao M; Fogo AB; Kirabo A; Harrison DG
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35608913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoproteasomal Processing of Isolevuglandin Adducts in Hypertension.
    de la Visitación N; Chen W; Krishnan J; Van Beusecum JP; Amarnath V; Hennen EM; Zhao S; Saleem M; Ao M; Harrison DG; Patrick DM
    bioRxiv; 2023 Apr; ():. PubMed ID: 37383945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.